February 01, 2023 - Preconvention Day 1
Time Now for Better Choices: Delivering the Value of Immunotherapy for Triple Negative Breast Cancer Patients
Dr. Rubi K. Li
Navigating Treatment options in HR (+), HER2 (-) Metastatic Breast Cancer
Dr. Marie Belle D. Francia
February 02, 2023 - Preconvention Day 2
HR + BRCA Treatment Landscape
Dr. Ma. Luisa Tiambeng
February 03, 2023 - Convention Day 1
Breast Cancer Biomarker Testing
Dr. Manuelito A. Madrid
Management of Estrogen Preceptor + HER 2 Negative Metastatic Breast Cancer: Bringing Together Clinical & Real-World Evidence
Dr. Adam M. Brufsky
The Best Practice and Clinical Experience with Mammaprint in US/EU
Dr. Gul Basaran
February 04, 2023 - Convention Day 2
BRCA in Early Breast Cancer
Dr. Shaheena Dawood
Updates and Changing Paradigms in HER2+ Breast Cancer
Dr. Shaheena Dawood
Obstetrics Gynecology-Reproductive Endocrinology and Fertility
Dr. Virgilio M. Novero Jr.